Literature DB >> 31626941

Minimally Invasive Open Conversion for Late EVAR Failure.

Francesco Stilo1, Nunzio Montelione2, Vincenzo Catanese3, Rossella C Vigliotti3, Francesco Spinelli1.   

Abstract

OBJECTIVE: With the increasing use of endovascular aortic aneurysm repair (EVAR), open repair after aortic stent grafting is of growing interest. The surgical conversion treatment may be a very challenging process with high mortality and in-hospital complication rates. The aim of this article is to present our experience in patients with EVAR failure treated by minimally invasive open conversion (MOC) and its technical aspects.
METHODS: A retrospective study was conducted on a prospectively compiled computerized database of consecutive patients treated by MOC at our institution between May 2014 and June 2018. Indications for treatment were endoleaks with sac growth at least >5 mm in the last 6 months and failure of previous endovascular tentative for aneurysm sealing. Demographics of the patients, reason for conversion, previous endovascular procedures, surgical outcomes, and survival were reviewed. MOC was performed by a small abdominal incision, infrarenal clamping, and partial explantation of the endograft in all patients.
RESULTS: A total of 10 patients were treated during the study period. The mean interval to MOC after EVAR was 45.1 months (range, 14-128). Indications for MOC included type Ia endoleak in three patients (30%), persistent type II EL in four (40%), and type III EL in one patient (10%), indeterminate or type V EL in two (20%). At 30 days, no deaths or reinterventions were reported, and major complication rate was 10% (one postoperative pneumonia). At mean follow-up of 22.9 ± 15.9 months, no reinterventions were described. Death rate was (20%) with one aneurysm-related death (10%) for graft infection 32 months after MOC and one (10%) cardiac event at 18 months.
CONCLUSIONS: Despite the potential high risk of open conversion, MOC appears to be a safe surgical solution for EVAR failure. This potentially challenging operation may be improved with minimally invasive techniques that are presented.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31626941     DOI: 10.1016/j.avsg.2019.08.087

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  First case of aorto-bi-iliac endograft thrombotic infection by Listeria monocytogenes: A case report.

Authors:  Enrico M Zardi; Nunzio Montelione; Vincenzo Catanese; Teresa Gabellini; Marco Caricato; Domenico M Zardi; Francesco Spinelli; Francesco Stilo
Journal:  Exp Ther Med       Date:  2022-06-06       Impact factor: 2.751

2.  Single centre experience with Excluder® stent graft; 17-year outcome.

Authors:  Ziga Snoj; Tjasa Tomazin; Vladka Salapura; Dimitrij Kuhelj
Journal:  Radiol Oncol       Date:  2022-04-13       Impact factor: 4.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.